Dr. Hemant Malhotra | Oncology | Omnicuris

Home

Courses

MedShots

Survey

Verifying...

Loading, please wait...

Consult AIRA AI

About Us Contact Us FAQs Privacy Policy Terms of Use ISO

Download Our Mobile App

Copyright © 2026 Omnicuris Healthcare Pvt Ltd. All rights reserved.

"Wherever the art of Medicine is loved, there is also a love of Humanity."

Hippocrates

Made with❤️byOmnicuris

© 2026 Omnicuris Healthcare Pvt Ltd.

AIRA MedShots Profile

Dr. Hemant Malhotra | Oncology | Omnicuris

Dr. Hemant Malhotra

Medical Expert

Qualification

Oncology

Location

India

Qualification

Oncology

Location

India

Educational Content

10 Sessions

HPV Update: Its types, Disease associations, Screening, and Vaccination.

HPV Update: Its types, Disease associations, Screening, and Vaccination.

A WHO Life-course approach for a translational cancer-prevention.

A WHO Life-course approach for a translational cancer-prevention.

Incidence, Mortality and prevalence of Cervical Cancer.

Incidence, Mortality and prevalence of Cervical Cancer.

NSCLC- Approved 2nd line Therapy and NCCN Recommendations

NSCLC- Approved 2nd line Therapy and NCCN Recommendations

NSCLC- Approved 1st line Therapy and Pivotal Studies

NSCLC- Approved 1st line Therapy and Pivotal Studies

Metastatic NSCLC- Chemotherapy and Immunotherapy

Metastatic NSCLC- Chemotherapy and Immunotherapy

Non-Small Cell Lung Cancer (NSCLC)- Biomedical Testing and Treatment

Non-Small Cell Lung Cancer (NSCLC)- Biomedical Testing and Treatment

More Treatment Approaches for RRMM

More Treatment Approaches for RRMM

BCMA-Targeting Drugs - ADC, BiTEs and CAR T-Cell Therapies

BCMA-Targeting Drugs - ADC, BiTEs and CAR T-Cell Therapies

Emerging Options for Multiple Myeloma - Selinexor, Isatuximab and Daratumumab

Emerging Options for Multiple Myeloma - Selinexor, Isatuximab and Daratumumab